Search Options Stock News and Analysis

https://www.schaeffersresearch.com/content/analysis/2020/06/04/regn-could-take-a-breather-this-month

6/4/2020 1:41 PM

Over the past two weeks, we've been exploring some of the best S&P 500 stocks to own in June, historically. Now, with help from Schaeffer's Senior Quantitative Analyst Rocky White, we'll shift gears...

Drug Stock Stays Hot After COVID-19 Treatment Update

https://www.schaeffersresearch.com/content/analysis/2020/03/17/drug-stock-stays-hot-after-covid-19-treatment-update

3/17/2020 2:27 PM

One of the best stocks on the Nasdaq today is Regeneron Pharmaceuticals Inc (NASDAQ:REGN), last seen up 10.8% to trade at $488.42. This comes after the drugmaker announced it had identified hundreds o...

Put Buying Picks Up During Regeneron Stock Rally

https://www.schaeffersresearch.com/content/options/2019/12/13/put-buying-picks-up-during-regeneron-stock-rally

12/13/2019 2:45 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has been rallying hard since its lows near $270 from early October, checking in 0.9% higher today at $375.40 -- which would be its best close since April --...

Regeneron Pharmaceuticals Stock Retreats After Asthma Antibody Data

https://www.schaeffersresearch.com/content/news/2019/06/21/regeneron-pharmaceuticals-stock-retreats-after-asthma-antibody-data

6/21/2019 9:45 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is moving lower this morning, last seen down 0.9% at $317.63, even after the drugmaker revealed positive topline results from a Phase 2 study of its IL-33 a...

Regeneron Pharmaceuticals Set to Test Chart Support After Earnings

https://www.schaeffersresearch.com/content/news/2019/05/07/regeneron-pharmaceuticals-set-to-test-chart-support-after-earnings

5/7/2019 9:22 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stock is trading down 3.7% ahead of the bell, after the biotech reported slimmer-than-expected first-quarter adjusted earnings of $4.45 per share. Regeneron...

PEOPLE ALSO SEARCH FOR